Alexandra Oudot is an expert in Biochemistry at Centre Georges François Leclerc (France). Alexandra Oudot has authored 52 publications, the most recent in 2026. SLR score: 178 (community average: 125). How the SLR is computed.

LeadR Profile

Alexandra Oudot Centre Georges François Leclerc France
178 ScienceLeadR Reputation 178
Network Map

Biochemistry

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026

Source: PubMed

University of Burgundy

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 52

Citations

Citations: 1 230 1st author: 11 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Toward Personalized Theranostics: A Modular PET Platform for Antibody-Based Imaging and Therapy.
PMID 42621760 — chelating agents, biomedical research, positron-emission tomography, neoplasms, foundations, therapeutics, trastuzumab
Adv Sci (Weinh)20260
Collagen-targeted PET imaging for progressive experimental lung fibrosis quantification and monitoring of efficacy of anti-fibrotic therapies.
PMID 39990206 — bleomycin, lung, nanomedicine, fibrosis, positron-emission tomography, disease progression, collagen, pulmonary fibrosis, therapeutics, tissues
Theranostics20250
Iodixanol as a New Contrast Agent for Cyanoacrylate Embolization: A Preliminary In Vivo Swine Study.
PMID 38137399 — arteries, necrosis, enbucrilate, renal artery, contrast media, cyanoacrylates
Biomedicines20230
Identification of the Proteins Determining the Blood Circulation Time of Nanoparticles.
PMID 37379064 — lipoproteins, nanoparticles, factor vii, nanotechnology, apolipoprotein c-i, alpha-2-hs-glycoprotein, blood circulation time
ACS Nano202330
IL-1RAP, a Key Therapeutic Target in Cancer.
PMID 36499246 — carcinogenesis, neoplasm metastasis, cells, therapeutics, neoplasms
Int J Mol Sci202217

LeadR Networks

Main global connection map